Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
Quick Stats
Jan 30, 202659.9
AI Score
HOLD0.1
Volume Ratio
Mar 05, 2026
Next Earnings
11
+ve Days (30d)
18
-ve Days (30d)
REVB Stock Summary
Last updated Jan 30, 2026
REVB is currently trading at $2.03, positioned below its 200-day moving average of $2.53, suggesting bearish momentum. The stock has a 52-week range of $0.47 to $13.8.
Technical Analysis: The 50-day moving average stands at $0.96, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 73.985, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.758, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates REVB at 59.9/100 with a HOLD recommendation.
REVB (Revelation Biosciences, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 73.985 |
| CMF (20) | -0.758 |
| ROC (10) | 125.581 |
| ADX (14) | 28.492 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.173 |
| AROONOSC (14) | 7.143 |
| WILLAMS %R (14) | -15.676 |
| MFI (14) | 10.628 |
REVB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
REVB Price vs Max Options Open Interest
REVB Max Change In Options Open Interest
REVB Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REVB Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REVB Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REVB Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Revelation Biosciences, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
REVB Moving Averages Analysis
Revelation Biosciences, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
REVB (Revelation Biosciences, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.13 |
| 20 | 1.01 |
| 30 | 0.96 |
| 50 | 0.96 |
| 100 | 1.17 |
| 200 | 2.53 |
REVB Fundamental Analysis
| P/E (Forward) | 0.8875 |
| P/E (Trailing) | 0.0064 |
| Market Cap ($) | 3.1 million |
| Earnings/Share ($) | 325 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -36.6 |
| EPS Estimate Next Year ($) | -14.32 |
| WallStreet Target Price ($) | 85 |
| Most Recent Quarter |